MINIMED GROUP INC
MMEDNASDAQ🏆 #1197 by market capUS Equity
$19.46▲ $0.26 (+1.33%)
Latest quoteTrack MMED
Get earnings, price moves & breaking news on Telegram
24h▲ 1.3%
7d▲ 6.4%
14d▲ 8.3%
30d▼ 2.8%
ytd—
1y—
🏦Market Cap
$5.48B
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
—
Insufficient data
Trading Snapshot
- Day Range
- $19.23 – $19.55
- 52-Week Range
- $10.65 – $24.43
- Volume (shares)
- 31,065
- Avg Volume (shares)
- —
- Shares Outstanding
- 281.4M
- Next Earnings
- —
Fundamentals Snapshot
- Annual Revenue
- $3.10B
- Last Q Revenue
- $843M
- P/E Ratio
- —
- P/S Ratio
- —
- EPS (TTM)
- —
- Dividend Yield
- —
- Dilution (1yr)
- +0.0%
MINIMED GROUP INC
MMEDFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$3.1B▲ +14.3% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
54.2%▼ −3.6% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$49M▼ −124.3% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$420M▲ +692.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
281.0M▲ +0.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$148M▼ −$202M YoY
StockOtter · stockotter.spaceAbout MINIMED GROUP INC
MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst data unavailable.
Latest News & Updates
News unavailable.